5MinuteHematology

KRd (ASPIRE) Protocol

Curated Five Minute Hematology reference for KRd (ASPIRE). Open the approved protocol in 5MH Tools.

Multiple Myeloma Treatment regimen

Open protocol

Continue to the reviewed 5MH Tools protocol reference for regimen details, schedule, supportive-care context, evidence and source transparency.

Open protocol All 5MH Tools
Protocol reference KRd (ASPIRE) · Multiple Myeloma · Treatment regimen · v1.3.1
Aliases KRD, KRd, krd, carfilzomib lenalidomide dexamethasone, ASPIRE, ASPIRE KRd
Medical review Reviewed 2026-10-07 · ASPIRE: 28-day cycles; carfilzomib through cycle 18, then Rd until progression or unacceptable toxicity
Protocol type Defined multi-drug regimen with a specified treatment schedule.
Source transparency Evidence references are available in the approved 5MH protocol.
For qualified healthcare professionals · Educational and professional reference use only · Verify clinically relevant information against original sources